Cancer Med

Breast cancer risk and prevention in 2024: An overview from the Breast Cancer UK - Breast Cancer Prevention Conference.

Stordal B, Harvie M, Antoniou MN, ..., Vandenberg LN, Evans DG

Cancer Med 13 (18) e70255 [2024-09-00; online 2024-09-24]

Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer.

Salomonsson A, Micke P, Mattsson JSM, ..., Planck M, Brunnström H

Cancer Med 9 (15) 5609-5619 [2020-08-00; online 2020-06-03]

Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients.

Grenda A, Błach J, Szczyrek M, ..., Sawicki M, Milanowski J

Cancer Med 9 (2) 605-614 [2020-01-00; online 2019-12-03]

Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients.

Aasebø KØ, Dragomir A, Sundström M, ..., Glimelius B, Sorbye H

Cancer Med 8 (7) 3623-3635 [2019-07-00; online 2019-05-09]

A cis-eQTL of HLA-DRB1 and a frameshift mutation of MICA contribute to the pattern of association of HLA alleles with cervical cancer.

Chen D, Gyllensten U

Cancer Med 3 (2) 445-452 [2014-04-00; online 2014-02-12]

A variant upstream of HLA-DRB1 and multiple variants in MICA influence susceptibility to cervical cancer in a Swedish population.

Chen D, Hammer J, Lindquist D, Idahl A, Gyllensten U

Cancer Med 3 (1) 190-198 [2014-02-00; online 2014-01-07]